Archive for June, 2012

Driving While Texting = Vehicular Homicide

Saturday, June 30th, 2012

While civil punishments and lesser criminal charges for drivers who text are becoming increasingly common, homicide convictions for texting drivers who cause fatal accidents have been, until recently, untested. Now, however, a Massachusetts driver has been convicted of motor vehicle homicide (otherwise known as vehicular homicide) when his texting while driving caused a fatal crash. Our experienced distracted driving attorneys believe that this will be only the first of many such convictions.

Aaeon Dveau, an 18-year-old Massachusetts driver, was the first to be charged and convicted for such an offense. Deveau pled not guilty, but his argument was based on the question of whether he was, in fact, texting at the time of the crash – not whether a charge of vehicular manslaughter was valid for a texting driver.

The crash occurred when Deveau’s vehicle began swerving and crossed the center line of the road. He then crashed headlong into a pickup truck, killing the driver – a 55-year-old father of three.
In addition to the charge of motor vehicle homicide, Deveau faced charges of negligent operation of a motor vehicle, using a mobile phone while operating a motor vehicle, reading or sending an electronic message, a marked lanes violation, and two counts of negligent operation and injury from mobile phone use.

Deveau argued that his vehicle crossed the center line because he was distracted by the large volume of homework he was facing, not due to texting while driving. He argued that he had not texted since he left the parking lot at his work, a local grocery store. According to his testimony, he then placed the phone on the passenger seat, where it remained until after the crash.

Phone records, however, showed that this was a case of distracted driving due to texting. Deveau sent a text message at 2:34, received a return message at 2:35, and crashed at 2:36. In total, Deveau sent 193 texts on the day of the crash, February 20, 2011.

Deveau’s behavior after the crash also influenced the jury. When police took a videotaped statement from him shortly after the crash, he asked them, on tape, “If anything happens to them, if one passes away, what would happen to me?” The jury apparently believed, as the prosecution argued, that this showed consciousness that his texting caused the accident.

Deveau now faces sentencing. He is eligible for up to four years in prison. The top distracted driving attorneys of Passen Law Group, however, believe that this is insufficient punishment. With study after study showing that drivers, particularly teens and young adults, are ignoring laws against texting while driving, our criminal justice system must step up to convince these young people to stop – as concern for their own safety and that of others has failed to do.

In the meantime, civil attorneys such as those at Passen Law Group will continue to fill the void of justice for those injured by distracted drivers, including those who text on the road. If you or someone you love was injured in a car accident, and you believe that distracted driving was to blame, call for a free consultation and evaluation of your case.

For a free consultation with an experienced Chicago distracted driving lawyer at Passen Law Group, call us at (312) 527-4500.

FDA Moves to Stop Misleading “Corn Sugar” Labeling

Friday, June 29th, 2012

Our consumer protection attorneys were pleased to hear of the FDA’s recent decision on labels using the term “corn sugar.” For some time, certain food manufacturers have added high-fructose corn syrup to soda, breakfast cereal and virtually all other processed foods and beverages sold in grocery stores today. However, in recent years, high-fructose corn syrup has come under fire for the myriad of problems to which it contributes, including obesity, diabetes, and even, due to the method of processing, mercury poisoning.

As a result, many manufacturers have simply sought to mislead consumers about the contents of the foods they sell, leaving the ingredients intact but changing the ingredient list to read “corn sugar” instead. Now, at last, the FDA has taken action to stop this deceptive practice.

Manufacturers have argued that they should be permitted to continue labeling high-fructose corn syrup as “corn sugar” in the interests of consumers. Food manufacturers, together with the Corn Refiners Association, argued that the two terms were equivalent both nutritionally and metabolically.

The FDA, however, disagreed. The agency ruled that the term “corn sugar,” as applied to high-fructose corn syrup, was inconsistent with both the common understanding of the term “sugar” and the term’s dictionary definition. As such, using the term could mislead consumers.

Additionally, the FDA noted that the use of the term could not only expose consumers to the dangers described above, but could cause more direct harm. This is because “corn sugar” is already used to refer to dextrose, a dry, crystalized sugar made from corn starch. This sugar is essential to certain individuals whose bodies cannot process fructose. Thus, labeling high-fructose corn syrup as “corn sugar” could risk the health and lives of these individuals.

While the FDA ruling serves to protect consumers from this deceptive practice going forward, it does not put an end to legal claims based on prior labeling. For instance, there is litigation currently pending between the corn-syrup industry and the sugar industry over advertising that equated sugar and corn syrup. The ruling also does nothing to stop products liability claims by individuals injured by the mislabeling, such as those with the inability to process fructose.

For a free consultation with an experienced Chicago consumer protection lawyer at Passen Law Group, call us at (312) 527-4500.

Mesh Implants Dangerous and Defective

Tuesday, June 26th, 2012

In what is simply too common a story to our experienced product liability attorneys, mesh implants have become the latest medical treatment to skyrocket in usage, only to be proved dangerous and defective. Mesh implants went rapidly from a new, untested treatment to the standard, go-to treatment for middle aged and older women suffering from stress incontinence and pelvic organ prolapse. But transvaginal mesh implants have proven to be far more painful and dangerous then the conditions they were designed to treat.

In fact, transvaginal mesh implants can and do frequently cause life-altering, debilitating pain, infection, bleeding, painful or impossible intercourse, and other devastating side effects. The problems are so pronounced that a congressional investigation is now underway. The mesh implants also now come with mandated federal safety warnings. And now, hundreds of lawsuits are underway on behalf of victims of these dangerous implants. These combined events have led many, including our products liability lawyers, to question whether the FDA should simply remove the devices from the market entirely.

Transvaginal mesh can be made from biological or synthetic materials. It is put in place surgically, either using abdominal surgery, a laparoscope, or a transvaginal procedure. In theory, the mesh is then absorbed by the patient’s body, creating a permanent solution to prolapsed organs (organs falling out of place or even into the vagina) or incontinence.

However, particularly when the transvaginal procedure is used, there is a clear risk of serious complications. The FDA is thus imploring surgeons to consider using other treatments, rather than transvaginal mesh, to treat these conditions. In fact, the agency advises doctors that these conditions can almost always be successfully treated with other treatments, such as stitches or a removable “pressary” device. The agency has also ordered various mesh manufacturers to conduct additional long-term safety studies.

Meanwhile, the federal courts have consolidated hundreds of individual products liability lawsuits against mesh makers. Because various experts put the rate of complications at between 1 percent and 10 percent of women treated, these cases still represent only a fraction of actual victims. And the fact that the body absorbs the mesh means that the damage is often irreversible, as the mesh cannot be removed.

We urge Congress and the FDA to take immediate, definitive action to stop the use of dangerous transvaginal mesh implants. In the meantime, private products liability attorneys such as we at Passen Law Group will continue to seek justice on behalf of the victims of this latest defective medical product.

For a free consultation with an experienced Chicago products liability lawyer at Passen Law Group, call us at (312) 527-4500.

Illinois House Advances Misguided Bond Limitation Bill

Monday, June 25th, 2012

The experienced personal injury attorneys of Passen Law Group were disappointed to see the Illinois House take action last week to cap appellate bonds. While this action may prevent extremely rare instances of excessive bonds, it also acts to curtail the rights of successful plaintiffs and put them at risk of losing their recovery should the circumstances of the offender change.

When a plaintiff prevails in a civil lawsuit in Illinois, the defendant may appeal the ruling to a higher court. However, to protect the plaintiff’s rights, an appealing defendant – particularly a corporate defendant – is typically required to put up a bond to secure the amount of the judgment. That way, should the company’s fortunes change during the course of the appeal, or the defendant attempt to declare bankruptcy after losing the appeal, the plaintiff will still be able to recover for the harm done to her, as awarded by the lower court.

This system generally works well to protect the rights of victorious personal injury and product liability plaintiffs, while still allowing defendants their own appellate rights. There is, however, very rarely an outlying bond award which makes observers suspect abuse.

That was the case recently when Philip Morris USA was ordered to post a $12 billion bond in order to appeal the verdict in a Madison County tobacco lawsuit. After a verdict that the company had misled consumers about the dangers of “lite” cigarettes, a $10.1 billion judgment was entered. The court then set the bond at $12 million, to provide for interest during the period of the appeal. The Illinois Supreme Court later reduced the bond to $6 billion, before finally reversing the original judgment.
Thus, the Illinois House has now passed a bill limiting appellate bonds to $250 million. This limit would be enforced regardless of the size of the award in the lower court.

While we appreciate that the Philip Morris case was an outlier, our Chicago product liability attorneys do not believe that the correct response is to punish all plaintiffs for this aberration. Arbitrary caps on bonds, much like arbitrary caps on damages, impair the rights of plaintiffs who have suffered the worst injuries, at the hands of defendants who have engaged in the worst misconduct.

We urge the Illinois Senate, to whom the bill now returns, to kill this inappropriate and unfair legislation. We hope that, through such action, the rights of Illinois plaintiffs can still be preserved and protected.

For a free consultation with an experienced Chicago personal injury lawyer at Passen Law Group, call us at (312) 527-4500.

New Study Reveals the Workings of the Brain’s “Emergency Worker” Cells

Saturday, June 23rd, 2012

Researchers have known for some time now that, when the brain is injured or damaged, the brain’s “emergency workers” help to minimize and even stop the damage. These repair cells, known as microglia, move to the injured part of the brain and consume, or “eat” cellular debris and injured or dead neurons, containing the injury before it can spread.

It has long puzzled brain injury researchers how these cells locate the injury in order to do their work. A new study by researchers at the European Molecular Biology Laboratory (EMBL) in Heidelberg, Germany, and published in Developmental Cell, has established exactly how microglia locate the injuries.

When a brain neuron is injured, it sends out a sort of distress call, by releasing glutamate molecules. Nearby neurons, responding to the glutamate, absorb calcium. As the glutamate spreads, so does the calcium-absorbing effect. As the neurons absorb calcium, they also release another molecule, ATP. Microglia which detect ATP then move towards it, following the trail of ATP to the injury site.

The brain injury attorneys hope that this research enables researchers to develop more effective treatments for traumatic and non-traumatic brain injuries, as well as situations when microglia are for some reason unable to locate and thus contain an injury.

This new knowledge could be crucial in quickly treating traumatic brain injuries, and could also prove key in conditions such as Alzheimer’s and Parkinson’s, which affect microglia’s ability to detect the site of injury. We applaud the scientists who have taken this important step forward, and encourage others to build on this important research.

For a free consultation with an experienced Chicago brain injury lawyer at Passen Law Group, call us at (312) 527-4500.